地球生命的分子结构具有独特的“手性”（chirality）：天然氨基酸绝大多数为左手性，而构成DNA和RNA骨架的糖分子则为右手性。2024年底发表在《科学》（Science）杂志上的一篇论文引发了全球警惕，研究指出若人工合成完全镜像的手性细菌，其生物分子特征将导致人类及动植物免疫系统无法识别，同时也对变形虫等单细胞捕食者不可消化，并能免疫噬菌体的自然调控，从而可能在逃逸后引发无法阻断的瘟疫或生态灾难。虽然镜像生物无法代谢天然的左手性氨基酸和右手性糖，但印度国家生物科学中心的迪帕·阿加什（Deepa Agashe）在新加坡镜像生命会议上展示的最新量化数据显示，土壤、血液和肠道中富含充足的“非手性”（achiral）营养物质，足以支撑大肠杆菌存活，这意味着镜像细菌可在缺乏天敌的环境中无限繁殖，犹如入侵澳大利亚且无法根除的甘蔗蟾蜍。
合成生物学与人工智能的迅猛结合，正大幅缩短镜像生命问世的时间窗口。原本在2024年被认为至少需要15年才能实现的技术突破，如今正通过“整体合成”与“逐步改造”两条路径加速逼近。哈佛医学院乔治·丘奇（George Church）指出，明尼苏达大学于今年7月公布了一种“马铃薯状细胞”（spud cell），其在脂质囊泡内仅凭7个小型质粒染色体和编码的36种酶（远少于自然界小型细菌的上百种），便成功实现了摄食、生长与细胞分裂；与此同时，丘奇实验室已成功改造了细胞装配蛋白质的机制，实现了非标准（包括右手性）氨基酸的掺入。尽管制药界对右旋肽（D-peptides）和镜像核酸（spiegelmers）的抗降解长效药用价值抱有兴趣，但完全可以通过无生命化学合成制备，无需冒灭绝性生态风险制造镜像生物。
鉴于镜像生物武器具有不可控性，美、英、德政府及联合国秘书长科学咨询委员会已于今年3月相继发布风险通报并表达关切。新加坡闭门会议旨在敲定具体的全球监管路线图，丘奇教授等学者提出了将DNA合成的病原体审查机制全面拓展至镜像生命、重奖内部举报人、对违规科研人员处以监禁极刑，乃至对从业研究者引入心理评估机制等具体建议。由于目前该领域尚未形成强大的商业游说资本或地缘战略利益阻力，国际社会正迎来在技术成熟前建立预防性监管防线的黄金窗口，以避免这一可能摧毁生态系统的生物安全危机演变为现实。
Biological life on Earth exhibits strict molecular chirality: essential amino acids are almost uniformly left-handed, whereas the sugar backbones of DNA and RNA are right-handed. A landmark paper published in Science in late 2024 warned that synthesizing artificial "mirror-image" bacteria could unleash uncontrollable ecological devastation. Because terrestrial immune systems and natural predators such as amoebae and bacteriophages are chiral-specific, they would fail to recognize, digest, or regulate mirror organisms. While critics initially argued that mirror cells would starve in nature, empirical data presented by Deepa Agashe at the Singapore Conference on Mirror Life revealed that soil, mammalian blood, and digestive tracts contain vast quantities of achiral nutrients sufficient to sustain baseline bacterial growth like E. coli, effectively enabling mirror pathogens to multiply unchecked like an incurable invasive species.
Accelerated by artificial intelligence and synthetic biology, the timeline for creating mirror life is shrinking rapidly from an anticipated 15-year horizon. Researchers are advancing along two distinct technical vectors: whole-cell synthesis and incremental cellular conversion. In July, University of Minnesota bioengineers demonstrated a synthetic "spud cell" containing merely seven plasmid chromosomes encoding 36 enzymes enclosed within a fatty membrane, successfully achieving metabolism, growth, and division with far fewer components than natural bacteria. Simultaneously, George Church’s laboratory at Harvard Medical School modified standard cellular translation machinery to integrate non-standard amino acids, including mirror forms. Although opposite-handed biomolecules such as D-peptides and spiegelmers offer prolonged therapeutic lifespans, these pharmaceutical agents can be produced chemically without generating self-replicating mirror organisms.
With a bioweapon based on mirror life being inherently uncontrollable, regulatory momentum is building before vested commercial lobbies entrench themselves. American, British, and German authorities, along with the UN Secretary-General’s Scientific Advisory Board in March, have formally acknowledged the catastrophic biosecurity hazard. Recommendations finalized in Singapore advocate extending strict oversight frameworks from commercial DNA synthesis to chiral biotechnology, instituting bounties for whistleblowers, and mandating severe criminal penalties—including imprisonment comparable to punishments for illicit human embryo editing—alongside psychological screening for researchers. Because mirror life currently lacks entrenched economic lobbies or military utility, early proactive multilateral governance offers a vital, fleeting window to avert irreversible planetary biocontamination.
Source: It may soon be possible to create “mirror life”
Subtitle: Such research poses risks for humanity and the planet
Dateline: Oct 1st 2026\n